Spots Global Cancer Trial Database for cinacalcet
Every month we try and update this database with for cinacalcet cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) | NCT03299244 | Secondary Hyper... Chronic Kidney ... | Etelcalcetide Cinacalcet | 18 Years - | Amgen | |
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | NCT00977080 | Chronic Kidney ... Secondary Hyper... Hemodialysis | Paricalcitol Cinacalcet | 18 Years - | Abbott | |
| Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis | NCT01181531 | Hyperparathyroi... | Traditional Vit... Cinacalcet | 18 Years - | Amgen | |
| Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis | NCT00446329 | Secondary Hyper... | cinacalcet | 18 Years - | Papageorgiou General Hospital | |
| Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis | NCT00446329 | Secondary Hyper... | cinacalcet | 18 Years - | Papageorgiou General Hospital | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients | NCT01447368 | Kidney Failure Secondary Hyper... Vascular Diseas... | Cinacalcet Surgical total ... | 18 Years - 75 Years | The University of Hong Kong | |
| Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis | NCT00446329 | Secondary Hyper... | cinacalcet | 18 Years - | Papageorgiou General Hospital | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD) | NCT01479088 | Secondary Hyper... | Cinacalcet HCl | 2 Years - 18 Years | Istituto Giannina Gaslini | |
| Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) | NCT03299244 | Secondary Hyper... Chronic Kidney ... | Etelcalcetide Cinacalcet | 18 Years - | Amgen | |
| A Study of SHR6508 in Secondary Hyperparathyroidism | NCT05663411 | Secondary Hyper... | SHR6508 SHR6508 Cinacalcet | 18 Years - | Shanghai Hengrui Pharmaceutical Co., Ltd. | |
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | NCT00977080 | Chronic Kidney ... Secondary Hyper... Hemodialysis | Paricalcitol Cinacalcet | 18 Years - | Abbott | |
| Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet | NCT01896232 | Secondary Hyper... Chronic Kidney ... | Etelcalcetide Cinacalcet Oral Placebo Intravenous Pla... | 18 Years - 85 Years | Amgen | |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients | NCT01447368 | Kidney Failure Secondary Hyper... Vascular Diseas... | Cinacalcet Surgical total ... | 18 Years - 75 Years | The University of Hong Kong | |
| Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level | NCT01101113 | Secondary Hyper... | cinacalcet control | 18 Years - 70 Years | Seoul National University Hospital | |
| Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease | NCT01290029 | Chronic Kidney ... Hyperparathyroi... Secondary Hyper... | Cinacalcet | 28 Days - 2190 Days | Amgen | |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis | NCT02133404 | Secondary Hyper... | ASP7991 Cinacalcet Placebo | 20 Years - 79 Years | Astellas Pharma Inc | |
| START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism | NCT00132431 | Kidney Disease Secondary Hyper... Chronic Kidney ... | Sensipar | 18 Years - | Amgen | |
| Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT | NCT03123406 | Hyperparathyroi... | Cinacalcet HCl | 18 Years - 75 Years | Kyowa Kirin Co., Ltd. | |
| A Study of SHR6508 in Secondary Hyperparathyroidism | NCT05663411 | Secondary Hyper... | SHR6508 SHR6508 Cinacalcet | 18 Years - | Shanghai Hengrui Pharmaceutical Co., Ltd. | |
| Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level | NCT01101113 | Secondary Hyper... | cinacalcet control | 18 Years - 70 Years | Seoul National University Hospital | |
| Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease | NCT01290029 | Chronic Kidney ... Hyperparathyroi... Secondary Hyper... | Cinacalcet | 28 Days - 2190 Days | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
